| Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population. | |
| | |
MedLine Citation:
|
PMID: 16990424 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Despite the rarity of pheochromocytoma, diagnosis is important because of the dangers of uncontrolled severe hypertension and the availability of very effective surgical treatment. Urinary or plasma catecholamines or catecholamine derivatives are commonly used to screen for pheochromocytomas before imaging, but data from 24-h urinary metanephrine results, patient age, and sex may better predict tumors in populations with a low pretest probability. METHODS: We retrospectively studied outcomes of an unselected population (1819 patients) referred to a tertiary hospital laboratory for urinary metanephrine testing and investigated the usefulness of some simple derivative measures for detecting pheochromocytoma. We normalized values for urinary 24-h excretion of metanephrine, normetanephrine, and 3-methoxytyramine by dividing by an age- and sex-specific reference range. We then compared pheochromocytoma prediction by the use of products of these normalized measures with the gold standard of biopsy-confirmed tumor. RESULTS: The product of the excretion of normalized metanephrine (nMAD) and normalized normetanephrine (nNMT) (nMAD.nNMT) was a highly sensitive (100%) and specific (99.1%) measure, yielding a positive predictive value of 82%. ROC curves were not improved by including the normalized 3-methoxytyramine concentrations in the product. The test for nMAD.nNMT gave higher sensitivity and specificity than the tests for either substance alone. CONCLUSION: The test for nMAD.nNMT is a useful measure for identifying pheochromocytoma in a population with a low pretest probability. |
| | |
Authors:
|
Keith L Brain; Jonathan Kay; Brian Shine |
Related Documents
:
|
11549664 - Performance of the basal aldosterone to renin ratio and of the renin stimulation test b... 10560594 - A perspective on standardizing the predictive power of noninvasive cardiovascular tests... 14967164 - Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy. 2806714 - Oral bioavailability of atenolol. 19668954 - Reproducibility of water drinking test performed at different times of the day. 1520154 - Colorectal cancer screening: optimal compliance with postal faecal occult blood test. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-09-21 |
Journal Detail:
|
Title: Clinical chemistry Volume: 52 ISSN: 0009-9147 ISO Abbreviation: Clin. Chem. Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2006-10-27 Completed Date: 2006-12-05 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 9421549 Medline TA: Clin Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 2060-4 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, University of Oxford, and Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, United Kingdom. keith.brain@pharm.ox.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenal Gland Neoplasms
/
diagnosis*,
epidemiology,
urine* Cohort Studies Female Great Britain / epidemiology Humans Male Mass Screening / methods* Metanephrine / urine* Middle Aged Pheochromocytoma / diagnosis*, epidemiology, urine* Predictive Value of Tests ROC Curve Referral and Consultation Retrospective Studies |
| Grant Support | |
ID/Acronym/Agency:
|
074128//Wellcome Trust; //Wellcome Trust |
| Chemical | |
Reg. No./Substance:
|
5001-33-2/Metanephrine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.
Next Document: Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of cor...